Digitisation | April 17, 2025
Rockwell Automation empowers NKP Pharma achieve regulatory compliance
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
Rising demands and advancements in eye care drive growth
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
The EIR was issued following an inspection of the facility conducted from June 10 to June 13, 2024
Genomics is transforming the future of modern medicine and treatment modalities across specialties
The plant will have installed production capacity of 3,120 MT/month
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities
The approved product, Mesalamine Suppositories 1000 mg, has an estimated U.S. market size of US$ 29 million
This change is subject to the approval of the shareholders of the company, the Ministry of Corporate Affairs and other statutory and regulatory authorities,
Subscribe To Our Newsletter & Stay Updated
